Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06420531 · ClinicalTrials.gov registry record · NA
Milk And Growth In Children (MAGIC) Born Very Preterm: A Randomized Trial
A NA study of Prematurity, sponsored by University of Alabama at Birmingham.
- Recruiting
- Registry status
- NA
- Development phase
- 486
- Enrollment target
- 4
- Study locations
NCT06420531: Recruiting NA study of Prematurity, sponsored by University of Alabama at Birmingham.
NCT06420531 is a NA study of Prematurity that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 486 participants, above the 188-participant average among 21 other Prematurity trials with a reported enrollment target (159% higher). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06420531, a NA study of Prematurity, is actively recruiting participants, sponsored by University of Alabama at Birmingham.
- RECRUITING
- Registry status
- NA
- Development phase
- 486 participants
- Enrollment target
- 4
- Study locations
Study Summary
The goal of this multi-center randomized, parallel group trial is to determine the effect of human milk diets ranging between 180 and 200 mL/kg/day on the body composition outcomes of moderately preterm infants born between 27 and 31 weeks of gestation.
Primary Outcome
Estimated by bioelectric impedance analysis. FFM measurements will be converted into Z-scores using updated, sex specific reference curves of body composition in preterm infants
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Human milk
Study Locations (4)
Texas
- University of Texas Southwestern Medical Center at Dallas - Dallas
- University of Texas Health Science Center at Houston - Houston
Alabama
- University of Alabama at Birmingham - Birmingham
Mississippi
- University of Mississippi Medical Center - Jackson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 486 participants |
| Start Date | 2025-09-16 |
| Est. Completion | 2030-08-30 |
| Phase | NA |
What NCT06420531 shows while recruiting
NCT06420531 is an interventional study that assigns participants to a tested intervention. The registered 486 participants enrollment target is mid-sized for trials with a published cap, above the 188-participant average among 21 other Prematurity trials with a reported enrollment target (159% higher).
The record links to 1 condition, with Prematurity appearing as the primary indexed condition, and to 1 intervention - of which Human milk is the first listed.
NCT06420531 reports a single indexed study location in Texas, Alabama, Mississippi.
Frequently Asked Questions
What is clinical trial NCT06420531 about?
NCT06420531 is a clinical study titled "Milk And Growth In Children (MAGIC) Born Very Preterm: A Randomized Trial". The goal of this multi-center randomized, parallel group trial is to determine the effect of human milk diets ranging between 180 and 200 mL/kg/day on the body composition outcomes of moderately preterm infants born between 27 and 31 weeks of gestation.
What is the current status of trial NCT06420531?
This trial is currently recruiting. It is a NA study. The enrollment target is 486 participants. The study started on 2025-09-16. Estimated completion is 2030-08-30.
What conditions does trial NCT06420531 study?
This clinical trial studies the following conditions: Prematurity.
What interventions are being tested in trial NCT06420531?
The interventions under investigation include: Human milk (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06420531?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06420531 being conducted?
This trial has 4 study locations across Alabama, Mississippi, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prematurity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06420531's enrollment target sits among peer trials
486 4th of 21 higher than 18 of 21 other Prematurity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Prematurity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Impact of Music Medicine on Preterm Brain Development and Behavior
RECRUITING · NA
-
The Effects of Entrainment on Respiratory Stability and Cerebral Oxygenation in Preterm Infants
RECRUITING · NA
-
Nourishing Tomorrow: Role of Medically Tailored Groceries in Addressing Food Insecurity During Pregnancy
RECRUITING · NA
-
Early Human Milk Fortification After Early, Exclusive, Enteral Nutrition in Very Preterm Infants
ACTIVE NOT RECRUITING · NA
-
NEO Rehab Program for Premature Infants at Risk for Cerebral Palsy
COMPLETED · NA
-
NEO Rehab for Infants at Risk of Cerebral Palsy
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07097142 · 486 participants · Phase 3
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
- NCT06948435 · 487 participants · Phase 3
A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL1
- NCT06952530 · 487 participants · Phase 3
A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL2
- NCT07124910 · 485 participants · Phase 3
Comparison of Epi-ON Corneal Collagen Crosslinking Performed Using an 18-Minute UVA Exposure vs. a 24-Minute UVA Exposure on Eyes With Ectatic Corneal Diseases
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI